Company · Healthtech & Bio

Sincrolab

sincrolab.es ↗ ·Madrid ·Seed

Sincrolab is a Madrid-based digital therapeutics company that builds AI-personalised cognitive training delivered as prescribable video games, with its flagship product Sea of Heroes treating ADHD in children aged roughly 7-15 plus solutions for adults with cognitive impairment. Founded by clinical neuropsychologists, it works with 800+ therapists and over 100 specialised centres and backs its products with published clinical evidence. It is a seed-stage healthtech that raised a €1.7M round in early 2025 led by Clave Capital's Clave Innohealth fund, with a follow-on from Eoniq.fund in June 2026 at a reported €8.5M pre-money valuation.

Founded
2013
Founders
3
News
0
Rounds
2
Investors
5
SectorsHealthtech, Digital Therapeutics, AI, Mental Health, Medtech Start-up MapHealthtech & Bio › Consumer & telehealth services

Profile updated 15 Aug 2026

Founders

Daniel Garrido
Co-founder (former CTO)
—
Ignacio de Ramón Burgos
CEO & Co-founder
María Laorden Baeza
Co-founder
—

Global models

No comparables on record yet.

Investors 5

Funding rounds 2

Other · €100K
Eoniq Fund made a €100K follow-on (cumulative €335K) in Sincrolab's AI-prescribed cognitive-training therapeutics for ADHD and cognitive def…
2026-06-19
Seed · €1.7M
Sincrolab raised €1.7M in a round led by Clave Capital through its healthcare fund Clave Innohealth, with Growth Venture Partners, Eoniq Fun…
2024-06-20

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close